• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Comprehensive Overview of 2,6-Difluoro-3-(methylsulfamoyl)benzoic acid (CAS No. 1039993-93-5)

2,6-Difluoro-3-(methylsulfamoyl)benzoic acid (CAS No. 1039993-93-5) is a fluorinated benzoic acid derivative with significant applications in pharmaceutical and agrochemical research. This compound, characterized by its sulfamoyl and carboxylic acid functional groups, has garnered attention for its potential as a building block in drug discovery. Researchers are increasingly exploring its utility in designing enzyme inhibitors and bioactive molecules, particularly in targeting inflammatory pathways and metabolic disorders.

The structural uniqueness of 2,6-difluoro-3-(methylsulfamoyl)benzoic acid lies in its difluorinated aromatic ring, which enhances metabolic stability and bioavailability—a critical factor in modern medicinal chemistry. Recent studies highlight its role in optimizing lead compounds for diseases like diabetes and autoimmune conditions, aligning with the growing demand for precision medicine solutions. Its CAS No. 1039993-93-5 is frequently cited in patent literature, underscoring its industrial relevance.

From a synthetic perspective, this compound serves as a versatile intermediate for cross-coupling reactions and amide bond formation. Its compatibility with green chemistry principles—such as reduced solvent waste—resonates with the pharmaceutical industry's shift toward sustainable practices. Analysts note rising interest in fluorinated sulfonamides, driven by their improved pharmacokinetic profiles, placing 1039993-93-5 at the forefront of innovation.

Beyond pharmaceuticals, 2,6-difluoro-3-(methylsulfamoyl)benzoic acid finds niche applications in material science, particularly in designing high-performance polymers with enhanced thermal resistance. Its electron-withdrawing properties make it valuable for tuning electronic materials, a topic gaining traction in organic electronics research. Regulatory agencies classify it as non-hazardous under standard handling conditions, facilitating its adoption in diverse R&D settings.

In summary, CAS No. 1039993-93-5 represents a multifaceted tool for researchers addressing challenges in drug development and advanced materials. Its combination of fluorine and sulfonamide moieties offers a strategic advantage in molecular design, reflecting broader trends toward structure-activity relationship optimization. As the scientific community prioritizes small-molecule therapeutics, this compound’s role is poised to expand, supported by robust synthetic protocols and safety profiles.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)